Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analyzing laboratory marker changes in AIDS clinical trials.

J D Dawson1, S W Lagakos

  • 1Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115.

Journal of Acquired Immune Deficiency Syndromes
|January 1, 1991
PubMed
Summary

This study compares methods for analyzing repeated lab marker data in clinical trials, like CD4 counts. The regression slope method is generally the most powerful for detecting treatment differences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staphylococcus aureus in the nose and throat of Iowan families.

Epidemiology and infection·2018
Same author

Design and initial operation of a two-color soft x-ray camera system on the Compact Toroidal Hybrid experiment.

The Review of scientific instruments·2014
Same author

Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.

Biometrics·2011
Same author

Real-life driving outcomes in Parkinson disease.

Neurology·2011
Same author

Indication-specific 6-h systolic blood pressure thresholds can approximate 24-h determination of blood pressure control.

Journal of human hypertension·2010
Same author

Road safety in drivers with Parkinson disease.

Neurology·2009

Area of Science:

  • Biostatistics
  • Immunology
  • Clinical Trials

Background:

  • Repeated laboratory marker measurements (e.g., CD4 counts, HIV p24 antigen) are crucial endpoints in comparative clinical trials.
  • Analyzing trends in these markers over time is essential for evaluating treatment efficacy.

Purpose of the Study:

  • To compare the statistical power of different distribution-free summary statistics for analyzing repeated marker data.
  • To identify the most efficient method for comparing treatment groups based on longitudinal marker data.

Main Methods:

  • Examined three summary statistics: least-squares regression slope, average of last 'r' measurements, and difference between early and late measurements.
  • Compared statistical power under various marker time trend models.
  • Discussed and illustrated adaptations for handling missing data.

Related Experiment Videos

Main Results:

  • The least-squares regression slope was found to be generally more statistically powerful than the other summary statistics.
  • The analysis demonstrated the utility of these methods in a real-world AIDS clinical trial setting.

Conclusions:

  • The regression slope is a highly efficient summary statistic for analyzing longitudinal immunologic markers in clinical trials.
  • The findings provide guidance for selecting appropriate statistical methods to analyze repeated measures data, especially in HIV/AIDS research.